Spark Therapeutics (ONCE) Tops Q4 EPS by 49c

Spark Therapeutics (NASDAQ: ONCE) reported Q4 EPS of ($0.24), $0.49 better than the analyst estimate of ($0.73).

For earnings history and earnings-related data on Spark Therapeutics (ONCE) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Ocean Power Technologies revises fiscal 2026 results after audit
• Target raises full-year sales forecast amid ongoing turnaround drive